Skip to content
TrialScanner

NCT04200573

Effect of Hepatic Impairment on the Pharmacokinetics of a Single Dose of TD-9855

Phase 1CompletedTBPHLead

Registry record

Lead sponsor
Theravance Biopharma
Conditions
Symptomatic Neurogenic Orthostatic Hypertension; nOH
Primary completion
Aug 19, 2021Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04200573 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.